会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 74. 发明授权
    • Controlled release drug delivery
    • 控制释放药物递送
    • US06168801A
    • 2001-01-02
    • US09272428
    • 1999-03-19
    • Ronald W. Heil, Jr.Bruce H. KenKnight
    • Ronald W. Heil, Jr.Bruce H. KenKnight
    • A61F202
    • A61K9/0024
    • Biologically active materials are provided in a cylindrical carrier medium with better control over the rate of delivery and length of time of delivery by providing a carrier having dissolved or dispersed therein at least two compounds having a common biologically active nucleus, but with different solubility parameters. The combination of the two different variants of the same drug with different solubility parameters provides the material with control over the rate of release of the compounds (by varying the proportions of the variants) and most importantly, extending the useful life of the device by enabling release of effective levels of the compounds over a longer period of time. The cylindrical carrier medium, comprised of silicone, further includes a tail, a skirt, or a rate-limiting membrane.
    • 生物活性材料提供在圆柱形载体介质中,通过提供具有溶解或分散在其中的至少两种具有共同的生物活性核,但具有不同溶解度参数的化合物的载体,可以更好地控制输送速率和输送时间。 具有不同溶解度参数的相同药物的两种不同变体的组合提供了材料对化合物释放速率的控制(通过改变变体的比例),最重要的是通过使得能够延长器件的使用寿命 在更长的时间内释放有效含量的化合物。 由硅树脂构成的圆柱形载体介质还包括尾部,裙部或限速膜。
    • 79. 发明授权
    • Vagus nerve neurostimulator with multiple patient-selectable modes for treating chronic cardiac dysfunction
    • 迷走神经神经刺激器具有多种患者可选择的治疗慢性心脏功能障碍的模式
    • US08571654B2
    • 2013-10-29
    • US13352244
    • 2012-01-17
    • Imad LibbusBadri AmurthurBruce H. KenKnight
    • Imad LibbusBadri AmurthurBruce H. KenKnight
    • A61N1/365
    • A61N1/0551A61N1/36053A61N1/36114A61N1/3727
    • A vagus nerve neurostimulator system with multiple patient-selectable modes for treating chronic cardiac dysfunction is provided. An implantable neurostimulator includes a pulse generator coupled to a therapy lead terminated by a pair of helical electrodes positioned over a cervical vagus nerve. The pulse generator is configured to deliver through the helical electrodes continuously-cycling, intermittent and periodic electrical stimulation that is parametrically defined to bi-directionally propagate through nerve fibers in the cervical vagus nerve. The implantable neurostimulator includes a magnetic switch configured to switch the pulse generator between a plurality of operating modes that are each separately selectable in response to a unique and remotely-applied magnetic signal. An external controller includes patient-actuatable controls configured to enable selection of one of the operating modes of the pulse generator. The external controller includes an electromagnetic transmitter configured to output the magnetic signal uniquely associated with the operating mode as selected with the controls.
    • 提供了一种具有多种患者可选择的用于治疗慢性心脏功能障碍的模式的迷走神经神经刺激器系统。 可植入的神经刺激器包括一个脉冲发生器,该脉冲发生器耦合到由位于颈部迷走神经上的一对螺旋电极终止的治疗引线。 脉冲发生器被配置为通过螺旋电极连续循环,间歇和周期性电刺激传递,其被参数限定以通过颈部迷走神经中的神经纤维双向传播。 可植入神经刺激器包括磁开关,其被配置为在多个操作模式之间切换脉冲发生器,所述多个操作模式可以响应于独特的和远程施加的磁信号而分别可选择。 外部控制器包括被配置为能够选择脉冲发生器的一个操作模式的患者致动控制。 外部控制器包括电磁发射机,其被配置为输出与通过控制选择的操作模式唯一相关联的磁信号。